|
2013 Journal Article Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trialDiodati, Jean G., Saucedo, Jorge F., French, John K., Fung, Anthony Y., Cardillo, Tracy E., Henneges, Carsten, Effron, Mark B., Fisher, Harold N. and Angiolillo, Dominick J. (2013). Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trial. Circulation-Cardiovascular Interventions, 6 (5), 567-574. doi: 10.1161/CIRCINTERVENTIONS.112.000063 |
|
2013 Journal Article Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathwaysBraun, Oscar O., Angiolillo, Dominick J., Ferreiro, Jose L., Jakubowski, Joseph A., Winters, Kenneth J., Effron, Mark B., Duvvuru, Suman, Costigan, Timothy M., Sundseth, Scott S., Walker, Joseph R., Saucedo, Jorge F., Kleiman, Neal S. and Varenhorst, Christoph (2013). Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways. Thrombosis and Haemostasis, 110 (6), 1223-1231. doi: 10.1160/TH13-03-0263 |
|
2013 Conference Publication Contemporary use of platelet function and pharmacogenomic testing among acute myocardial infarction patients treated with PCI in the United States: insights from the TRANSLATE-ACS studyWang, T. Y., Henry, T. D., Mccoy, L. A., Berger, P. B., Cohen, D. J., Effron, M. B., Zettler, M., Vaitkus, P. T., Messenger, J. C. and Peterson, E. D. (2013). Contemporary use of platelet function and pharmacogenomic testing among acute myocardial infarction patients treated with PCI in the United States: insights from the TRANSLATE-ACS study. Congress of the European-Society-of-Cardiology (ESC), Amsterdam Netherlands, Aug 31-Sep 04, 2013. OXFORD: OXFORD UNIV PRESS. |
|
2013 Journal Article Adherence and persistence with prasugrel following acute coronary syndrome with percutaneous coronary interventionNordstrom, Beth L., Simeone, Jason C., Zhao, Zhenxiang, Molife, Cliff, McCollam, Patrick L., Ye, Xin and Effron, Mark B. (2013). Adherence and persistence with prasugrel following acute coronary syndrome with percutaneous coronary intervention. American Journal of Cardiovascular Drugs, 13 (4), 263-271. doi: 10.1007/s40256-013-0028-1 |
|
2013 Conference Publication EARLY CESSATION OF ADP RECEPTOR INHIBITORS AMONG ACUTE MYOCARDIAL INFARCTION PATIENTS TREATED WITH PCI: INSIGHTS FROM THE TRANSLATE-ACS STUDYFosbol, Emil L., Peterson, Eric, Honeycutt, Emily, Zettler, Marjorie, Messenger, John, Waksman, Ron, Effron, Mark, Vaitkus, Paul, Cohen, David and Wang, Tracy (2013). EARLY CESSATION OF ADP RECEPTOR INHIBITORS AMONG ACUTE MYOCARDIAL INFARCTION PATIENTS TREATED WITH PCI: INSIGHTS FROM THE TRANSLATE-ACS STUDY. 62nd Annual Scientific Session of the American-College-of-Cardiology, San Francisco Ca, Mar 09-11, 2013. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(13)61592-2 |
|
2013 Conference Publication THE ASSOCIATION OF DISCHARGE ASPIRIN DOSE AND OUTCOMES IN ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM THE TRANSLATE-ACS STUDYXian, Ying, Wang, Tracy, Kaltenbach, Lisa, Effron, Mark, Henry, Timothy, Bach, Richard, Zettler, Marjorie, Vaitkus, Paul, Fonarow, Gregg and Peterson, Eric (2013). THE ASSOCIATION OF DISCHARGE ASPIRIN DOSE AND OUTCOMES IN ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY. 62nd Annual Scientific Session of the American-College-of-Cardiology, San Francisco Ca, Mar 09-11, 2013. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(13)60112-6 |
|
2013 Journal Article TransRadial Education And Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research ConsortiumHess, Connie N., Rao, Sunil V., Kong, David F., Miller, Julie M., Anstrom, Kevin J., Bertrand, Olivier F., Collet, Jean-Philippe, Effron, Mark B., Eloff, Benjamin C., Fadiran, Emmanuel O., Farb, Andrew, Gilchrist, Ian C., Holmes, David R., Jacobs, Alice K., Kaul, Prashant, Newby, L. Kristin, Rutledge, David R., Tavris, Dale R., Tsai, Thomas T., White, Roseann M., Peterson, Eric D. and Krucoff, Mitchell W. (2013). TransRadial Education And Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium. American Heart Journal, 165 (3), 344-353.e1. doi: 10.1016/j.ahj.2012.09.008 |
|
2013 Journal Article Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) studySaucedo, Jorge F., Angiolillo, Dominick J., DeRaad, Roger, Frelinger, Andrew L., Gurbel, Paul A., Costigan, Timothy M., Jakubowski, Joseph A., Ojeh, Clement K., Duvvuru, Suman and Effron, Mark B. (2013). Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) study. Thrombosis and Haemostasis, 109 (2), 347-355. doi: 10.1160/TH12-06-0378 |
|
2012 Conference Publication Unplanned 30-Day Readmission Risk Among Patients with Acute Myocardial Infarction: A Report from TRANSLATE-ACSHess, Connie N., Wang, Tracy Y., Kaltenbach, Lisa, Honeycutt, Emily, Messenger, John C., Smith, William T., Zettler, Marjorie E., Effron, Mark B., Henry, Timothy D., Peterson, Eric D. and Fonarow, Gregg C. (2012). Unplanned 30-Day Readmission Risk Among Patients with Acute Myocardial Infarction: A Report from TRANSLATE-ACS. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2012 Conference Publication Transferring from Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients: High on-Treatment Platelet Reactivity Analysis of the TRIPLET TrialDiodati, Jean, Angiolillo, Dominick, Saucedo, Jorge, Cardillo, Tracy, Jakubowski, Joseph, Henneges, Carsten, Effron, Mark, Lipkin, Fred and Fisher, Harold (2012). Transferring from Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients: High on-Treatment Platelet Reactivity Analysis of the TRIPLET Trial. Transcatheter Cardiovascular Therapeutics (TCT) Symposium, Miami Fl, Oct 22-26, 2012. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jacc.2012.08.764 |
|
2012 Conference Publication TRANSFERRING FROM CLOPIDOGREL LOADING DOSE TO PRASUGREL LOADING DOSE IN ACUTE CORONARY SYNDROME PATIENTS: THE TRIPLET TRIALDiodati, J. G., Fung, A., Saucedo, J. F., Oguzhan, A., Gaxiola, E., Cardillo, T. E., Effron, M. B., Fisher, H. N., Henneges, C. and Angiolillo, D. J. (2012). TRANSFERRING FROM CLOPIDOGREL LOADING DOSE TO PRASUGREL LOADING DOSE IN ACUTE CORONARY SYNDROME PATIENTS: THE TRIPLET TRIAL. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.cjca.2012.07.655 |
|
2012 Conference Publication CHARACTERISTICS OF PATIENTS TREATED WITH THIENOPYRIDINES FOLLOWING ACS-PCINordstrom, B., Simeone, J. C., Zhao, Z., Molife, C., Mccollam, P. L., Ye, X. and Effron, M. B. (2012). CHARACTERISTICS OF PATIENTS TREATED WITH THIENOPYRIDINES FOLLOWING ACS-PCI. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jval.2012.03.721 |
|
2012 Conference Publication MEDICATION ADHERENCE AND PERSISTENCE OF PRASUGREL INITIATORS POST ACS-PCISimeone, J. C., Nordstrom, B., Zhao, Z., Molife, C., Mccollam, P. L., Ye, X. and Effron, M. B. (2012). MEDICATION ADHERENCE AND PERSISTENCE OF PRASUGREL INITIATORS POST ACS-PCI. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jval.2012.03.047 |
|
2012 Conference Publication MEDICATION NONADHERENCE AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE TRANSLATE-ACS STUDYMathews, Robin, Peterson, Eric, Honeycutt, Emily, Chin, Chee Tang, Ryan, Kelley, Effron, Mark, Zettler, Marjorie, Rozek, Maurice, Henry, Timothy and Wang, Tracy (2012). MEDICATION NONADHERENCE AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY. 61st Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC), Chicago Il, Mar 24-27, 2012. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(12)61815-4 |
|
2011 Conference Publication Post-discharge Bleeding and Thienopyridine Discontinuation among AMI Patients Treated with PCI: Insights from the TRANSLATE-ACS StudyWang, Tracy Y., Honeycutt, Emily, Henry, Timothy D., Effron, Mark B., Messenger, John C., Cohen, David J., Mark, Daniel B., Stone, Gregg W., Singh, Mandeep, Rozek, Maurice, Fonarow, Gregg C. and Peterson, Eric D. (2011). Post-discharge Bleeding and Thienopyridine Discontinuation among AMI Patients Treated with PCI: Insights from the TRANSLATE-ACS Study. 23rd Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium, San Francisco Ca, Nov 07-11, 2011. NEW YORK: ELSEVIER SCIENCE INC. |
|
2011 Journal Article Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational researchChin, Chee Tang, Wang, Tracy Y., Anstrom, Kevin J., Zhu, Baojin, Maa, Jen-Fue, Messenger, John C., Ryan, Kelley A., Davidson-Ray, Linda, Zettler, Marjorie, Effron, Mark B., Mark, Daniel B. and Peterson, Eric D. (2011). Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research. American Heart Journal, 162 (5), 844-851. doi: 10.1016/j.ahj.2011.08.021 |
|
2011 Journal Article A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 TrialAngiolillo, Dominick J., JoseBadimon, Juan, Saucedo, Jorge F., Frelinger, Andrew L., Michelson, Alan D., Jakubowski, Joseph A., Zhu, Baojin, Ojeh, Clement K., Baker, Brian A. and Effron, Mark B. (2011). A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial. European Heart Journal, 32 (7), 838-846. doi: 10.1093/eurheartj/ehq494 |
|
2011 Journal Article The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology dataZhu, Baojin, Effron, Mark B., Kulkarni, Pandurang M., Li, Ying G., Jakubowski, Joseph A., Miller, Debra L., Baker, Brian A., Luo, Junxiang, Small, David S. and Winters, Kenneth J. (2011). The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology data. Journal of Cardiovascular Pharmacology, 57 (3), 317-324. doi: 10.1097/FJC.0b013e3182073dfb |
|
2010 Journal Article Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes Results of the SWAP (SWitching Anti Platelet) StudyAngiolillo, Dominick J., Saucedo, Jorge F., DeRaad, Roger, Frelinger, Andrew L., Gurbel, Paul A., Costigan, Timothy M., Jakubowski, Joseph A., Ojeh, Clement K. and Effron, Mark B. (2010). Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes Results of the SWAP (SWitching Anti Platelet) Study. Journal of the American College of Cardiology, 56 (13), 1017-1023. doi: 10.1016/j.jacc.2010.02.072 |
|
2010 Conference Publication Lack of rebound in platelet reactivity following cessation of prasugrel or clopidogrel in type 2 diabetes mellitus patients with coronary artery disease: insights from OPTIMUS-3Angiolillo, D. J., Jakubowski, J. A., Frelinger, M. U., Zafar, M. U., Saucedo, J. F., Michelson, A. D., Zhu, B., Ojeh, C. K., Baker, B. A. and Effron, M. B. (2010). Lack of rebound in platelet reactivity following cessation of prasugrel or clopidogrel in type 2 diabetes mellitus patients with coronary artery disease: insights from OPTIMUS-3. ESC Congress, Stockholm Sweden, Aug 28-Sep 01, 2010. OXFORD: OXFORD UNIV PRESS. |
